Alterations in activity and energy expenditure contribute to lean phenotype in Fischer 344 rats lacking the cholecystokinin-1 receptor gene

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 303, Issue 12, 2012, Pages

  Blevins, James E ^a,b   Moralejo, Daniel H ^d   Wolden Hanson, Tami H ^a   Thatcher, Brendan S ^a   Ho, Jacqueline M ^a,b   Kaiyala, Karl J ^c   Matsumoto, Kozo ^e  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e KYOTO SANGYO UNIVERSITY   (Japan)

Author keywords

CCK1 receptors; Cholecystokinin; Meal size; Satiety

Indexed keywords

ANOREXIGENIC AGENT; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; DEVAZEPIDE; GLUCOSE; LEPTIN; MELANOTAN II;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; ENERGY EXPENDITURE; FISCHER 344 RAT; FOOD INTAKE; GASTROINTESTINAL TRACT; INTESTINE INNERVATION; LEAN BODY WEIGHT; LIGHT DARK CYCLE; MALE; MEAL; NERVE PROJECTION; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PHENOTYPE; PRIORITY JOURNAL; RAT; RECEPTOR GENE; RESPIRATORY QUOTIENT; RHOMBENCEPHALON; SENSORY NERVE; SIGNAL TRANSDUCTION; VAGUS NERVE;

ALPHA-MSH; ANIMALS; BODY WEIGHT; DEVAZEPIDE; EATING; ENERGY METABOLISM; GENE DELETION; MALE; MODELS, ANIMAL; MOTOR ACTIVITY; PEPTIDES, CYCLIC; PHENOTYPE; RATS; RATS, INBRED F344; RATS, MUTANT STRAINS; RECEPTOR, CHOLECYSTOKININ A; SEQUENCE DELETION; THINNESS;

EID: 84871331215     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00393.2012     Document Type: Article

References (56)

1. Arya R, Duggirala R, Jenkinson CP, Almasy L, Blangero J, O'Connell P, Stern MP. Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans. Am J Hum Genet 74: 272-282, 2004.
2. Asin KE, Gore PA Jr, Bednarz L, Holladay M, Nadzan AM. Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats. Brain Res 571: 169-174, 1992.
3. Bi S, Chen J, Behles RR, Hyun J, Kopin AS, Moran TH. Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors. Am J Physiol Regul Integr Comp Physiol 293: R55-R63, 2007.
4. Bi S, Ladenheim EE, Schwartz GJ, Moran TH. A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am J Physiol Regul Integr Comp Physiol 281: R254-R260, 2001.
5. Bi S, Moran TH. Actions of CCK in the controls of food intake and body weight: lessons from the CCK-A receptor deficient OLETF rat. Neuropeptides 36: 171-181, 2002.
6. Bi S, Scott KA, Hyun J, Ladenheim EE, Moran TH. Running wheel activity prevents hyperphagia and obesity in Otsuka Long-Evans Tokushima Fatty rats: role of hypothalamic signaling. Endocrinology 146: 1676-1685, 2005.
7. Bi S, Scott KA, Kopin AS, Moran TH. Differential roles for cholecystokinin a receptors in energy balance in rats and mice. Endocrinology 145: 3873-3880, 2004.
8. Blevins JE, Eakin TJ, Murphy JA, Schwartz MW, Baskin DG. Oxytocin innervation of caudal brainstem nuclei activated by cholecystokinin. Brain Res 993: 30-41, 2003.
9. Blevins JE, Overduin J, Fuller JM, Cummings DE, Matsumoto K, Moralejo DH. Normal feeding and body weight in Fischer 344 rats lacking the cholecystokinin-1 receptor gene. Brain Res 1255: 98-112, 2009.
10. Blevins JE, Stanley BG, Reidelberger RD. Brain regions where cholecystokinin suppresses feeding in rats. Brain Res 860: 1-10, 2000.
11. Bouret SG, Gorski JN, Patterson CM, Chen S, Levin BE, Simerly RB. Hypothalamic neural projections are permanently disrupted in diet-induced obese rats. Cell Metab 7: 179-185, 2008.
12. Chen DY, Deutsch JA, Gonzalez MF, Gu Y. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718. Neurosci Lett 149: 91-94, 1993.
13. Clerc P, Coll Constans MG, Lulka H, Broussaud S, Guigne C, Leung-Theung-Long S., Perrin C., Knauf C., Carpene C., Penicaud L., Seva C., Burcelin R., Valet P., Fourmy D., Dufresne M. Involvement of cholecystokinin 2 receptor in food intake regulation: hyperphagia and increased fat deposition in cholecystokinin 2 receptor-deficient mice. Endocrinology 148: 1039-1049, 2007.
14. Day HE, McKnight AT, Poat JA, Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 33: 719-727, 1994.
15. de Krom M, van der Schouw YT, Hendriks J, Ophoff RA, van Gils CH, Stolk RP, Grobbee DE, Adan R. Common genetic variations in CCK, leptin, and leptin receptor genes are associated with specific human eating patterns. Diabetes 56: 276-280, 2007.
16. Della-Fera MA, Baile CA. Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding. Science 206: 471-473, 1979.
17. Fraser KA, Raizada E, Davison JS. Oral-pharyngeal-esophageal and gastric cues contribute to meal-induced c-fos expression. Am J Physiol Regul Integr Comp Physiol 268: R223-R230, 1995.
18. Funakoshi A, Miyasaka K, Jimi A, Kawanai T, Takata Y, Kono A. Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats). Biochem Biophys Res Commun 199: 482-488, 1994.
19. Hill DR, Woodruff GN. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260. Brain Res 526: 276-283, 1990.
20. Honda T, Wada E, Battey JF, Wank SA. Differential gene expression of CCK(A) and CCK(B) receptors in the rat brain. Mol Cell Neurosci 4: 143-154, 1993.
21. Kaiyala KJ, Morton GJ, Leroux BG, Ogimoto K, Wisse B, Schwartz MW. Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes 59: 1657-1666, 2010.
22. Kaiyala KJ, Schwartz MW. Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes 60: 17-23, 2011.
23. Kopin AS, Mathes WF, McBride EW, Nguyen M, Al-Haider W, Schmitz F, Bonner-Weir S, Kanarek R, Beinborn M. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest 103: 383-391, 1999.
24. Lindblom J, Schioth HB, Watanobe H, Suda T, Wikberg JE, Bergstrom L. Downregulation of melanocortin receptors in brain areas involved in food intake and reward mechanisms in obese (OLETF) rats. Brain Res 852: 180-185, 2000.
25. Lo CM, King A, Samuelson LC, Kindel TL, Rider T, Jandacek RJ, Raybould HE, Woods SC, Tso P. Cholecystokinin knockout mice are resistant to high-fat diet-induced obesity. Gastroenterology 138: 1997-2005, 2010.
26. Lo CM, Samuelson LC, Chambers JB, King A, Heiman J, Jandacek RJ, Sakai RR, Benoit SC, Raybould HE, Woods SC, Tso P. Characterization of mice lacking the gene for cholecystokinin. Am J Physiol Regul Integr Comp Physiol 294: R803-R810, 2008.
27. Marchal-Victorion S, Vionnet N, Escrieut C, Dematos F, Dina C, Dufresne M, Vaysse N, Pradayrol L, Froguel P, Fourmy D. Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients. Pharmacogenetics 12: 23-30, 2002.
28. Miller LJ, Holicky EL, Ulrich CD, Wieben ED. Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology 109: 1375-1380, 1995.
29. Miyasaka K, Ichikawa M, Ohta M, Kanai S, Yoshida Y, Masuda M, Nagata A, Matsui T, Noda T, Takiguchi S, Takata Y, Kawanami T, Funakoshi A. Energy metabolism and turnover are increased in mice lacking the cholecystokinin-B receptor. J Nutr 132: 739-741, 2002.
30. Miyasaka K, Kanai S, Ohta M, Kawanami T, Kono A, Funakoshi A. Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene. Neurosci Lett 180: 143-146, 1994.
31. Monnikes H, Lauer G, Arnold R. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicinsensitive vagal afferents and CCK-A receptors in the rat. Brain Res 770: 277-288, 1997.
32. Montigny D. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Arch Gen Psychiatry 46: 511-517, 1989.
33. Moralejo DH, Ogino T, Kose H, Yamada T, Matsumoto K. Genetic verification of the role of CCK-AR in pancreatic proliferation and blood glucose and insulin regulation using a congenic rat carrying CCK-AR null allele. Res Commun Mol Pathol Pharmacol 109: 259-274, 2001.
34. Moralejo DH, Wei S, Wei K, Weksler-Zangen S, Koike G, Jacob HJ, Hirashima T, Kawano K, Sugiura K, Sasaki Y, Ogino T, Yamada T, Matsumoto K. Identification of quantitative trait loci for non-insulindependent diabetes mellitus that interact with body weight in the Otsuka Long-Evans Tokushima Fatty rat. Proc Assoc Am Physicians 110: 545-558, 1998.
35. Moran TH. Unraveling the obesity of OLETF rats. Physiol Behav 94: 71-78, 2007.
36. Moran TH, Ameglio PJ, Peyton HJ, Schwartz GJ, McHugh PR. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 265: R620-R624, 1993.
37. Moran TH, Ameglio PJ, Schwartz GJ, McHugh PR. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol Regul Integr Comp Physiol 262: R46-R50, 1992.
38. Moran TH, Katz LF, Plata-Salaman CR, Schwartz GJ. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol Regul Integr Comp Physiol 274: R618-R625, 1998.
39. Morton GJ, Thatcher BS, Reidelberger RD, Ogimoto K, Wolden-Hanson T, Baskin DG, Schwartz MW, Blevins JE. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab 302: E134-E144, 2012.
40. Ogino T, Wei S, Wei K, Moralejo DH, Kose H, Mizuno A, Shima K, Sasaki Y, Yamada T, Matsumoto K. Genetic evidence for obesity loci involved in the regulation of body fat distribution in obese type 2 diabetes rat, OLETF. Genomics 70: 19-25, 2000.
41. Olson BR, Freilino M, Hoffman GE, Stricker EM, Sved AF, Verbalis JG. c-Fos expression in rat brain and brainstem nuclei in response to treatments that alter food intake and gastric motility. Mol Cell Neurosci 4: 93-106, 1993.
42. Palkovits M, Mezey E, Eskay RL. Pro-opiomelanocortin-derived peptides (ACTH/beta-endorphin/alpha-MSH) in brainstem baroreceptor areas of the rat. Brain Res 436: 323-338, 1987.
43. Paxinos G, Watson C. The rat brain in stereotaxic coordinates (6th ed.). Burlington: Academic Press, 2007.
44. Reidelberger RD, ORourke MF. Potent cholecystokinin antagonist L-364,718 stimulates food intake in rats. Am J Physiol Regul Integr Comp Physiol 257: R1512-R1518, 1989.
45. Reidelberger RD, Varga G, Solomon TE. Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats. Peptides 12: 1215-1221, 1991.
46. Rinaman L, Verbalis JG, Stricker EM, Hoffman GE. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFos following peripheral administration of cholecystokinin. J Comp Neurol 338: 475-490, 1993.
47. Schick RR, Yaksh TL, Go VL. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats-pharmacological characterization of this action. Regul Pept 14: 277-291, 1986.
48. Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc Natl Acad Sci USA 88: 1130-1133, 1991.
49. Sugiura K, Miyake T, Taniguchi Y, Yamada T, Moralejo DH, Wei S, Wei K, Sasaki Y, Matsumoto K. Identification of novel non-insulin-dependent diabetes mellitus susceptibility loci in the Otsuka Long-Evans Tokushima fatty rat by MQM-mapping method. Mamm Genome 10: 1126-1131, 1999.
50. Wang L, Martinez V, Barrachina MD, Tache Y. Fos expression in the brain induced by peripheral injection of CCK or leptin plus CCK in fasted lean mice. Brain Res 791: 157-166, 1998.
51. Watanabe TK, Okuno S, Oga K, Mizoguchi-Miyakita A, Tsuji A, Yamasaki Y, Hishigaki H, Kanemoto N, Takagi T, Takahashi E, Irie Y, Nakamura Y, Tanigami A. Genetic dissection of "OLETF, " a rat model for non-insulin-dependent diabetes mellitus: quantitative trait locus analysis of (OLETF × BN) × OLETF. Genomics 58: 233-239, 1999.
52. Wei S, Wei K, Moralejo DH, Ogino T, Koike G, Jacob HJ, Sugiura K, Sasaki Y, Yamada T, Matsumoto K. Mapping and characterization of quantitative trait loci for non-insulin-dependent diabetes mellitus with an improved genetic map in the Otsuka Long-Evans Tokushima fatty rat. Mamm Genome 10: 249-258, 1999.
53. Weiland TJ, Voudouris NJ, Kent S. The role of CCK2 receptors in energy homeostasis: insights from the CCK2 receptor-deficient mouse. Physiol Behav 82: 471-476, 2004.
54. West DB, Fey D, Woods SC. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol Regul Integr Comp Physiol 246: R776-R787, 1984.
55. Wier JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109: 1-9, 1949.
56. Zhu G, Yan J, Smith WW, Moran TH, Bi S. Roles of dorsomedial hypothalamic cholecystokinin signaling in the controls of meal patterns and glucose homeostasis. Physiol Behav 105: 234-241, 2012.